Abu Dhabi Investment Council Co P.J.S.C

Position in ACLX — Arcellx, Inc.

CIK 1814011 ABU DHABI, C0

Position in ACLX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,220,389

New position

Shares Held

19,338

first reported quarter

Ownership

0.033%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#101

of 238 holders

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Abu Dhabi Investment Council Co P.J.S.C holds $176,329,045 across 5 Biotechnology names. ACLX ranks #3 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	1,739,859	$169,201,287
2	NRIX	Nurix Therapeutics, Inc.	185,311	$2,872,320
3	ACLX	Arcellx, Inc. This page	19,338	$2,220,389
4	ORIC	Oric Pharmaceuticals, Inc.	89,441	$1,133,217
5	CRSP	CRISPR Therapeutics AG	18,958	$901,832

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,220,389	19,338	—	Shares	Defined	2026-05-15
No filing history on record for this holder in this stock.